Explore All Access
Check if your research matches the topics covered in In Vivo?
- Degree of match
- Common matching concepts
- Additional journal recommendations
In Vivo : Impact Factor & More
eISSN: 1791-7549pISSN: 0258-851X
Share this on:
Check your submission readiness
Find out how your manuscript stacks up against 24 technical compliance and 6 language quality checks.
In Vivo Key Metrics
CiteScore 
3.1
Impact Factor
< 5
SJR
Q4Pharmacology
SNIP
0.84
Topics Covered on In Vivo
Cancer
Overall survival
Amino acid
Lung cancer
Sarcopenia
Lymph node
Neurofibromatosis
Chemoradiotherapy
Genotype
Hepatocellular carcinoma
Cerebral cortex
Breast cancer
Irradiation
Partial response
Thrombotic microangiopathy
Lung
Surgery
Reactive oxygen species
Adjuvant
Osteoid osteoma
In Vivo Journal Specifications
| Overview | |
| Publisher | INT INST ANTICANCER RESEARCH |
| Language | English |
| Frequency | Bi-monthly |
| General Details |
View less
One subscription packed with expert publication services and AI tools to get you published
Brought to you by 
Journal Selection Service
Benefit from our experts' recommendations of 3-5 best-suited journals, accompanied by a detailed Journal Selection report explaining the choices. Make informed decisions.
Journal Submission Service
Streamline your submission process with meticulous manuscript formatting to meet journal guidelines, crafting a tailored cover letter for the editor, and hassle-free account creation and submission
Bundle of AI tools for your research needs
Journal Finder, Paperpal, R Discovery, MindTheGraph and more
Planning to publish in In Vivo ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in In Vivo
The Impact of COVID-19 Infection During the Postoperative Period After Surgery for Ovarian Cancer
- 1 Jan 2022
- In Vivo
Pre-treatment CRP and Albumin Determines Prognosis for Unresectable Advanced Oesophageal Cancer
- 1 Jan 2022
- In Vivo
Medicinal Plants Used for Abdominal Discomfort – Information from Cancer Patients and Medical Students
- 1 Jan 2022
- In Vivo
Error Detectability of Isodose Volumes as ROIs in Prostate Intensity-modulated RT QA
- 1 Jan 2022
- In Vivo
Immunostimulation and Coagulopathy in COVID-19 Compared to Patients With H1N1 Pneumonia or Bacterial Sepsis
- 1 Jan 2022
- In Vivo
Cyclin-Dependent Kinase 4/6 Inhibitors: A Potential Breakthrough Therapy for Malignancies of Gastrointestinal Tract
- 1 Jan 2022
- In Vivo
The Impact of COVID-19 Infection During the Postoperative Period After Surgery for Ovarian Cancer
- 1 Jan 2022
- In Vivo
Pre-treatment CRP and Albumin Determines Prognosis for Unresectable Advanced Oesophageal Cancer
- 1 Jan 2022
- In Vivo
Medicinal Plants Used for Abdominal Discomfort – Information from Cancer Patients and Medical Students
- 1 Jan 2022
- In Vivo
Error Detectability of Isodose Volumes as ROIs in Prostate Intensity-modulated RT QA
- 1 Jan 2022
- In Vivo
Immunostimulation and Coagulopathy in COVID-19 Compared to Patients With H1N1 Pneumonia or Bacterial Sepsis
- 1 Jan 2022
- In Vivo
Cyclin-Dependent Kinase 4/6 Inhibitors: A Potential Breakthrough Therapy for Malignancies of Gastrointestinal Tract
- 1 Jan 2022
- In Vivo
FAQs on In Vivo
How long has In Vivo been actively publishing? 
In Vivo has been in operation since 1987 till date.
What is the publishing frequency of In Vivo?
In Vivo published with a Bi-monthly frequency.
How many articles did In Vivo publish last year?
In 2023, In Vivo publsihed undefined articles.
What is the eISSN & pISSN for In Vivo?
For In Vivo, eISSN is 1791-7549 and pISSN is 0258-851X.
What is Citescore for In Vivo?
Citescore for In Vivo is 3.1.
What is SNIP score for In Vivo?
SNIP score for In Vivo is 0.84.
What is the SJR for In Vivo?
SJR for In Vivo is Q4.
Who is the publisher of In Vivo?
INT INST ANTICANCER RESEARCH is the publisher of In Vivo.